NLRP3 and androgen insensitivity syndrome: Compared to the normal control group, the patients in the AIS group demonstrated significantly elevated serum levels of NLRP3 inflammasome and occludin upon admission (AIS group: NLRP3 inflammasome 56.59 (39.14–84.98) pg/mL vs. control group: NLRP3 inflammasome 33.24 (19.68–43.96) pg/mL, p < 0.001, Figure 2A; AIS group: occludin 97.42 (62.25–219.62) ng/mL vs. control group: occludin 44.54 (35.40–62.46) ng/mL, p < 0.001, Figure 2B).